Semiquantitative Analysis Using Standardized Uptake Value in I-FP-CIT SPECT/CT
Overview
Authors
Affiliations
Purpose: To evaluate potential of a semiquantitative method using standardized uptake value (SUV) in I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (I-FP-CIT) single photon emission computed tomography/computed tomography (SPECT/CT) compared with specific binding ratio (SBR).
Materials And Methods: First, we performed a phantom study to validate the accuracy of measuring SUV. 52 patients (25 male, 27 female; mean age of 75.1-year-old; 40 and 12 patients with neurodegenerative diseases with or without presynaptic dopaminergic deficits, respectively) were enrolled in a retrospective study. We measured SBR, maximum SUV, peak SUV, mean SUV, and striatum-to-background ratio of SUV (SUV) for striatum with lower I-FP-CIT uptake using commercial software. We calculated Pearson's correlation coefficient between SBR and SUV. We also calculated the sensitivity, specificity, and accuracy of each parameter for differential diagnosis.
Results: The phantom study revealed errors of <10% between theoretical and actual SUVs. Although there were significant correlations between SBR and all SUV-based parameters, SUV showed the most strong correlation with SBR (r = 0.877, p < 0.001). However, diagnostic capability of SUV (cutoff = 2.35) yielded to that of SBR (cutoff = 3.90) for diagnosing neurodegenerative diseases with presynaptic dopaminergic deficits (sensitivity of 85.0% vs 92.5%, specificity of 100% vs 91.7%, and accuracy of 88.5% vs 92.3%, respectively).
Conclusion: SBR is a promising parameter to aid differential diagnosis of neurodegenerative diseases with or without presynaptic dopaminergic deficit. Although technically acceptable, SUV may not be superior to SBR when clinically applied in I-FP-CIT SPECT/CT.
Sato T, Sawai S, Shimada N Jpn J Radiol. 2024; 43(1):78-90.
PMID: 39235674 PMC: 11717878. DOI: 10.1007/s11604-024-01648-7.
EANM practice guideline for quantitative SPECT-CT.
Dickson J, Armstrong I, Minguez Gabina P, Denis-Bacelar A, Krizsan A, Gear J Eur J Nucl Med Mol Imaging. 2022; 50(4):980-995.
PMID: 36469107 PMC: 9931838. DOI: 10.1007/s00259-022-06028-9.
Minami Y, Ogawa R, Ogura I Pol J Radiol. 2022; 87:e311-e315.
PMID: 35892069 PMC: 9288195. DOI: 10.5114/pjr.2022.117569.
Ogawa R, Ogura I Dentomaxillofac Radiol. 2021; 50(8):20200516.
PMID: 34019434 PMC: 8611283. DOI: 10.1259/dmfr.20200516.
Bando R, Otsuka H, Otani T, Matsuda N, Azane S, Kunikane Y Ann Nucl Med. 2021; 35(4):504-513.
PMID: 33630226 DOI: 10.1007/s12149-021-01592-w.